Ordenar

Buscar

17/11/2025 Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial
Lozano-Borbalas, A, Jordi-Ollero, O, Marruecos, J, Farre, N, Planas, I, Toledo, MD, Mesia, R, Navarro-Martin, A. Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1679589. PMID:41333216. IF:3.300(Q2/4D).
17/11/2025 Disease spectrum and long-term prognosis of patients with BAG3-associated neuromuscular diseases in Europe
Fernández-Eulate, G, Gitiaux, C, Thiele, S, Jungbluth, H, Potulska-Chromik, A, Marini-Bettolo, C, Davion, JB, Morís, G, Gallardo, E, Olivé, M, de la Hoz, CPD, Audic, F, Isapof, A, Walter, MC, Angelini, C, Bertini, E, Schara-Schmidt, U, Claeys, KG, Dohrn, MF, Dembele, M, Fer, F, Brochier, G, Evangelista, T, Kostera-Pruszczyk, A, Attarian, S, Straub, V, Domínguez-González, C, Vissing, J, Richard, P, Metay, C, Khraiche, D, Wahbi, K, Stojkovic, T. Disease spectrum and long-term prognosis of patients with BAG3-associated neuromuscular diseases in Europe. BRAIN. 2025; DOI:10.1093/brain/awaf223. PMID:40493734. IF:11.700(Q1/1D).
17/11/2025 Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design
Salgado, M, de la Camara-Gomez, J, García-Escobar, I, Alvarez-Llosa, RC, González-Villarroel, P, Garay, DF, Pàmpols-Felip, M, Guillot-Morales, M, Pelegrín-Mateo, FJ, Jimenez-Orozco, E, Sastre, J, De Castro, EM, Coma, E, Bouzas, LP, Ferrer-Pérez, AI, Mompradé-Olivé, E, Cousillas-Castiñeiras, A, Covela-Rúa, M, Rojas, M, Querol, R, Díaz, LR, Merino, M, Gil, M, Sánchez-Cánovas, M, Elías, T, Marrupe-González, D, Sánchez-Gil, B, Carmona-Campos, M, García-Ferron, M, Soria, JM, Muñoz, A. Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design. BMC CANCER. 2025; 25(1)DOI:10.1186/s12885-025-14620-z. PMID:41249955. IF:3.400(Q2/4D).
15/11/2025 Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men
Sauter, C, Dorn, H, Bueno-Lopez, A, Eggert, T, Schmid, G, Danker-Hopfe, H. Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men. ENVIRONMENTAL RESEARCH. 2025; 285DOI:10.1016/j.envres.2025.122479. PMID:40744201. IF:7.700(Q1/1D).